Not surprisingly, the overexpression of IF1 in hepatocarcinomas [20], bladder [21] and stomach [22] carcinomas and in gliomas [23] contributes, by different mechanisms, to cancer recurrence and progression. Here, ATP5IF1 is linked to carcinoma.